CompletedPhase 2NCT03519295
A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
Studying Carcinoma of the anal canal
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Principal Investigator
- Stefano KIM, MDUniversity Hospital of Besançon
- Intervention
- MPDL3280A(drug)
- Enrollment
- 97 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2023
Study locations (30)
- Clinique de l'Europe, Amiens, France
- Institut Sainte Catherine, Avignon, France
- CHRU Jean Minjoz, Besançon, France
- CHU Bordeaux - Hôpital Haut Lévêque, Bordeaux, France
- Centre François Baclesse, Caen, France
- Hôpitaux Civils de Colmar, Colmar, France
- Clinique des Cèdres, Cornebarrieu, France
- GHPSO Creil, Creil, France
- Centre Georges François Leclerc, Dijon, France
- Institut Hospitalier Franco-Britannique, Levallois-Perret, France
- Centre Oscar Lambert, Lille, France
- Centre Léon Bérard, Lyon, France
- Hôpital Jean Mermoz, Lyon, France
- CHU Timone, Marseille, France
- Hopital Montbéliard, Montbéliard, France
- +15 more locations on ClinicalTrials.gov
Collaborators
Roche Pharma AG
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03519295 on ClinicalTrials.govOther trials for Carcinoma of the anal canal
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07029152Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisUniversitair Ziekenhuis Brussel
- ACTIVE NOT RECRUITINGPHASE3NCT06866574A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesXiamen University
- RECRUITINGPHASE2NCT06640283Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical OutcomesInstituto do Cancer do Estado de São Paulo
- RECRUITINGNANCT06792604Host Genome Methylation: a Screening Tool in Anal Cancer DetectionAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE3NCT06207981Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCAFederation Francophone de Cancerologie Digestive
- RECRUITINGPHASE2NCT05661188Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)Grupo Espanol Multidisciplinario del Cancer Digestivo
- RECRUITINGNCT06327568Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensEuropean Institute of Oncology
- RECRUITINGNCT05438836Re-optimization Based Online Adaptive Radiotherapy of Anal CancerHerlev Hospital